Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
1. Two molecularly distinct rat P2Y receptors activated equally by adenosine-5'-triphosphate (ATP) and uridine-5'-triphosphate (UTP) (rP2Y2 and rP2Y4 receptors) were expressed in Xenopus oocytes and studied extensively to find ways to pharmacologically distinguish one from the other. 2. Both P2Y subtypes were activated fully by a number of nucleotides. Tested nucleotides were equipotent at rP2Y4 (ATP=UTP=CTP=GTP=ITP), but not at rP2Y2 (ATP=UTP>CTP>GTP>ITP). For dinucleotides (ApnA, n=2-6), rP2Y4 was only fully activated by Ap4A, which was as potent as ATP. All tested dinucleotides, except for Ap2A, fully activated rP2Y2, but none were as potent as ATP. ATP gamma S and BzATP fully activated rP2Y2, whereas ATP gamma S was a weak agonist and BzATP was inactive (as an agonist) at rP2Y4 receptors. 3. Each P2Y subtype showed different sensitivities to known P2 receptor antagonists. For rP2Y2, the potency order was suramin>PPADS= RB-2>TNP-ATP and suramin was a competitive antagonist (pA2, 5.40). For rP2Y4, the order was RB-2>suramin>PPADS> TNP-ATP and RB-2 was a competitive antagonist (pA2, 6.43). Also, BzATP was an antagonist at rP2Y4 receptors. 4. Extracellular acidification (from pH 8.0 to pH 5.5) enhanced the potency of ATP and UTP by 8-10-fold at rP2Y4 but did not affect agonist responses at rP2Y2 receptors. 5. Extracellular Zn2+ ions (0.1-300 microM) coapplied with ATP inhibited agonist responses at rP2Y4 but not at rP2Y2 receptors. 6. These two P2Y receptors differ significantly in terms of agonist and antagonist profiles, and the modulatory activities of extracellular H+ and Zn2+ ions. These pharmacological differences will help to distinguish between rP2Y2 and rP2Y4 receptors, in vivo.
Abbracchio,
Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family.
2003, Pubmed
Abbracchio,
Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family.
2003,
Pubmed
Barnard,
G protein-coupled receptors for ATP and other nucleotides: a new receptor family.
1994,
Pubmed
Bogdanov,
Molecular cloning and characterization of rat P2Y4 nucleotide receptor.
1998,
Pubmed
,
Xenbase
Brooks,
Bound and determined: a computer program for making buffers of defined ion concentrations.
1992,
Pubmed
Charlton,
Cloned and transfected P2Y4 receptors: characterization of a suramin and PPADS-insensitive response to UTP.
1996,
Pubmed
Clyne,
Mutational analysis of the conserved cysteines of the rat P2X2 purinoceptor.
2002,
Pubmed
,
Xenbase
Clyne,
The role of histidine residues in modulation of the rat P2X(2) purinoceptor by zinc and pH.
2002,
Pubmed
,
Xenbase
Communi,
Pharmacological characterization of the human P2Y11 receptor.
1999,
Pubmed
Communi,
Cloning and functional expression of a human uridine nucleotide receptor.
1995,
Pubmed
Dubyak,
Signal transduction by P2-purinergic receptors for extracellular ATP.
1991,
Pubmed
Dubyak,
Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides.
1993,
Pubmed
Erb,
Functional expression and photoaffinity labeling of a cloned P2U purinergic receptor.
1993,
Pubmed
Erb,
Site-directed mutagenesis of P2U purinoceptors. Positively charged amino acids in transmembrane helices 6 and 7 affect agonist potency and specificity.
1995,
Pubmed
Filippov,
Coupling of the nucleotide P2Y4 receptor to neuronal ion channels.
2003,
Pubmed
Freissmuth,
G protein antagonists.
1999,
Pubmed
Hiley,
Effects of pH on responses to adenosine, CGS 21680, carbachol and nitroprusside in the isolated perfused superior mesenteric arterial bed of the rat.
1995,
Pubmed
Kenakin,
Drug efficacy at G protein-coupled receptors.
2002,
Pubmed
Kennedy,
ATP, an agonist at the rat P2Y(4) receptor, is an antagonist at the human P2Y(4) receptor.
2000,
Pubmed
King,
P2 purinoceptor-activated inward currents in follicular oocytes of Xenopus laevis.
1996,
Pubmed
,
Xenbase
King,
Full sensitivity of P2X2 purinoceptor to ATP revealed by changing extracellular pH.
1996,
Pubmed
,
Xenbase
King,
Metabotropic receptors for ATP and UTP: exploring the correspondence between native and recombinant nucleotide receptors.
1998,
Pubmed
Lazarowski,
Cloning and functional characterization of two murine uridine nucleotide receptors reveal a potential target for correcting ion transport deficiency in cystic fibrosis gallbladder.
2001,
Pubmed
Lustig,
A nucleotide receptor in vascular endothelial cells is specifically activated by the fully ionized forms of ATP and UTP.
1992,
Pubmed
Lustig,
Expression cloning of an ATP receptor from mouse neuroblastoma cells.
1993,
Pubmed
,
Xenbase
Mundell,
Evidence for co-expression and desensitization of A2a and A2b adenosine receptors in NG108-15 cells.
1998,
Pubmed
Nguyen,
Cloning, expression, and chromosomal localization of the human uridine nucleotide receptor gene.
1995,
Pubmed
O'Connor,
Further subclassification of ATP receptors based on agonist studies.
1991,
Pubmed
Parr,
Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy.
1994,
Pubmed
Pendergast,
Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5'-polyphosphates.
2001,
Pubmed
Pintor,
Diadenosine polyphosphate-activated inward and outward currents in follicular oocytes of Xenopus laevis.
1996,
Pubmed
,
Xenbase
Ralevic,
Receptors for purines and pyrimidines.
1998,
Pubmed
Seye,
Overexpression of P2Y2 purinoceptor in intimal lesions of the rat aorta.
1997,
Pubmed
Smart,
Modulation of inhibitory and excitatory amino acid receptor ion channels by zinc.
1994,
Pubmed
Suarez-Huerta,
Molecular cloning and characterization of the mouse P2Y4 nucleotide receptor.
2001,
Pubmed
van der Weyden,
Pharmacological characterisation of the P2Y11 receptor in stably transfected haematological cell lines.
2000,
Pubmed
Vigne,
Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.
1999,
Pubmed
von Kügelgen,
Evidence for a vasoconstriction-mediating receptor for UTP, distinct from the P2 purinoceptor, in rabbit ear artery.
1987,
Pubmed
Webb,
Molecular cloning and characterization of the rat P2Y4 receptor.
1998,
Pubmed
Wildman,
Zn2+ modulation of ATP-responses at recombinant P2X2 receptors and its dependence on extracellular pH.
1998,
Pubmed
,
Xenbase
Zambon,
P2Y(2) receptor of MDCK cells: cloning, expression, and cell-specific signaling.
2000,
Pubmed
